Efficacy and safety of lemborexant in adults with insomnia: comparing Japanese and non-Japanese subgroups from the global, phase 3, randomized, double-blind, placebo-controlled SUNRISE 2 study | Zendy

Yuichi Inoue | Zendy; Takeshi Watanabe | Zendy; Shuya Takashima | Zendy; Takao Takase | Zendy; Kohei Ishikawa | Zendy; Naoki Kubota | Zendy; Jane Yardley | Zendy; Margaret Moline | Zendy

Open Access

Efficacy and safety of lemborexant in adults with insomnia: comparing Japanese and non-Japanese subgroups from the global, phase 3, randomized, double-blind, placebo-controlled SUNRISE 2 study

Author(s) -

Yuichi Inoue,

Takeshi Watanabe,

Shuya Takashima,

Takao Takase,

Kohei Ishikawa,

Naoki Kubota,

Jane Yardley,

Margaret Moline

Publication year - 2021

Publication title -

journal of clinical sleep medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.529

H-Index - 92

eISSN - 1550-9397

pISSN - 1550-9389

DOI - 10.5664/jcsm.9148

Subject(s) - placebo , medicine , sleep onset , insomnia , adverse effect , randomized controlled trial , body mass index , incidence (geometry) , physical therapy , psychiatry , optics , physics , alternative medicine , pathology

Whether there are racial differences in the efficacy/safety of hypnotics has not been sufficiently investigated. We aimed to evaluate the efficacy/safety of lemborexant 5 mg and lemborexant 10 mg vs placebo once daily in a subset of Japanese patients with insomnia and to compare the results with those of non-Japanese patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research